HUMAN GENOME SCIENCES INC Comprehensive Income
HUMAN GENOME SCIENCES INC reported Comprehensive Income of -$93.42 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-06-30 was -$93.42M.
- HUMAN GENOME SCIENCES INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-03-31 was -$91.79M.
- HUMAN GENOME SCIENCES INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2011-12-31 was -$82.06M.
- HUMAN GENOME SCIENCES INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2011-09-30 was -$88.96M.
- HUMAN GENOME SCIENCES INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2011 was -$383.68M.
- HUMAN GENOME SCIENCES INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2010 was -$233.47M, a 1433.05% decline from fiscal 2009.
- HUMAN GENOME SCIENCES INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2009 was $17.51M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2012-06-30 | -$93.42M 10-Q · filed 2012-07-26 | -$185.21M 10-Q · filed 2012-07-26 | -$267.28M derived: sum of 3 quarters · filed 2012-07-26 | -$356.24M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | -$91.79M 10-Q · filed 2012-04-26 | -$173.86M derived: sum of 2 quarters · filed 2012-04-26 | -$262.82M derived: sum of 3 quarters · filed 2012-04-26 | -$343.06M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | -$82.06M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$171.02M derived: sum of 2 quarters · filed 2012-02-28 | -$251.27M derived: sum of 3 quarters · filed 2012-07-26 | -$383.68M 10-K · filed 2012-02-28 |
| 2011-09-30 | -$88.96M 10-Q · filed 2011-10-28 | -$169.21M derived: sum of 2 quarters · filed 2012-07-26 | -$301.61M 10-Q · filed 2011-10-28 | -$393.04M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | -$80.25M 10-Q · filed 2012-07-26 | -$212.65M 10-Q · filed 2012-07-26 | -$304.08M derived: sum of 3 quarters · filed 2012-07-26 | -$341.73M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | -$132.41M 10-Q · filed 2012-04-26 | -$223.83M derived: sum of 2 quarters · filed 2012-04-26 | -$261.48M derived: sum of 3 quarters · filed 2012-04-26 | -$319.27M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | -$91.43M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$129.08M derived: sum of 2 quarters · filed 2012-02-28 | -$186.86M derived: sum of 3 quarters · filed 2012-02-28 | -$233.47M 10-K · filed 2012-02-28 |
| 2010-09-30 | -$37.65M 10-Q · filed 2011-10-28 | -$95.43M derived: sum of 2 quarters · filed 2011-10-28 | -$142.04M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | -$57.78M 10-Q · filed 2011-07-28 | -$104.39M 10-Q · filed 2011-07-28 | ||
| 2009-12-31 | $17.51M 10-K · filed 2012-02-28 |